ab40771 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab40771 は 8 報の論文で使用されています。

  • Liu P  et al. MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3. Cancer Cell Int 16:67 (2016). WB . PubMed: 27601936
  • Curado F  et al. ALK5 and ALK1 play antagonistic roles in transforming growth factor ß-induced podosome formation in aortic endothelial cells. Mol Cell Biol 34:4389-403 (2014). WB, ICC ; Mouse . PubMed: 25266657
  • Xie Y  et al. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation. J Biol Chem 288:2976-85 (2013). WB ; Human . PubMed: 23184937
  • Pereira PN  et al. Antagonism of Nodal signaling by BMP/Smad5 prevents ectopic primitive streak formation in the mouse amnion. Development 139:3343-54 (2012). PubMed: 22912414
  • Besson-Fournier C  et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120:431-9 (2012). WB . PubMed: 22611157
  • Nili M  et al. Soluble Repulsive Guidance Molecule c/Hemojuvelin Is a Broad Spectrum Bone Morphogenetic Protein (BMP) Antagonist and Inhibits both BMP2- and BMP6-mediated Signaling and Gene Expression. J Biol Chem 285:24783-92 (2010). WB ; Human . PubMed: 20530805
  • Wu R  et al. Derivation, characterization and differentiation of a new human embryonic stem cell line from a Chinese hatched blastocyst assisted by a non-contact laser system. Hum Cell 23:89-102 (2010). Human . PubMed: 20973834
  • Bharathy S  et al. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res 68:1656-66 (2008). WB ; Human . PubMed: 18339844

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"